Axsome Therapeutics, Inc.'s' stock surges 30% amid key catalysts. Learn why it's now rated a Buy wih upcoming data opportunities. Click for my AXSM update.

When it comes to investing on the behalf of people under the age of 18, you can fall foul of some punitive tax rules.

Nvidia (NASDAQ:NVDA) was rocked by Chinese artificial intelligence lab DeepSeek releasing an AI model that was more efficient ...

Can Costco's strong sales and global expansion sustain growth, making its premium valuation worth it? Its solid fundamentals ...

JM Financial shared a list of stocks in its latest research reports with price targets and buy, sell or hold recommendation.

The company's announcement that it was walking back its 2028 goals for smoke-free products warranted a closer look at its prospects.

Varun Beverages recommended a final dividend of Rs 0.50 per share. The 'Record Date' is yet to be fixed by the Board of ...

Nykaa shares are likely to be on investors' radar on Tuesday after it reported a 61% YoY increase in consolidated net profit in Q3 ...

Pliant Therapeutics paused its phase 2b/3 trial of bexotegrast for idiopathic pulmonary fibrosis due to DSMB recommendations.

The two metal stocks have seen negative sentiment in the short term due to Trump announcing steps to safeguard the US economy ...

Nuvama said the management’s efforts to reduce losses and improve overall profitability are showing results. Consolidated ...